Role of endoscopic retrograde cholangiopancreatography in the management of suspected choledocholithiasis

S. K. Sharma, K. A. Larson, Z. Adler, M. A. Goldfarb

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: Indications for endoscopic retrograde cholangiopancreatography (ERCP) are not precisely defined. With the increasing availability of magnetic resonance cholangiopancreatography (MRCP) and several prospective studies proving the accuracy of this modality, it is important to select appropriate criteria for invasive testing when common bile duct (CBD) pathology is suspected. Methods: We reviewed 200 consecutive ERCPs performed for jaundice, pancreatitis, noninvasive visualization of CBD stones, radiologic evidence of CBD dilatation, elevated liver function tests, or biliary colic. Diagnostic and therapeutic yields are determined for each indication and various combinations thereof. Results: Of the 180 ERCPs performed for suspected choledocholithiasis, 97 (53.8%) were performed for multiple indications, whereas 83 (46.2%) were performed for only one indication. One hundred two patients (56.6%) had CBD pathology, whereas 78 explorations (43.4%) were negative. If multiple indications for ERCP were present, the diagnostic yield was 85.6%. When there was only one indication, the diagnostic yield decreased to 25.3%. Conclusions: ERCP is an invasive procedure with significant morbidity that should be used selectively. MRCP may be a more appropriate initial evaluation of suspected CBD pathology in many patients.

Original languageEnglish
Pages (from-to)868-871
Number of pages4
JournalSurgical Endoscopy and Other Interventional Techniques
Volume17
Issue number6
DOIs
StatePublished - Jun 1 2003

Fingerprint

Choledocholithiasis
Endoscopic Retrograde Cholangiopancreatography
Common Bile Duct
Magnetic Resonance Cholangiopancreatography
Pathology
Colic
Liver Function Tests
Jaundice
Pancreatitis
Dilatation
Prospective Studies
Morbidity

Keywords

  • Choledocholithiasis
  • Common bile duct
  • Endoscopic retro grade cholangiopancreatography
  • Magnetic resonance cholangiopancreatography

ASJC Scopus subject areas

  • Surgery

Cite this

Role of endoscopic retrograde cholangiopancreatography in the management of suspected choledocholithiasis. / Sharma, S. K.; Larson, K. A.; Adler, Z.; Goldfarb, M. A.

In: Surgical Endoscopy and Other Interventional Techniques, Vol. 17, No. 6, 01.06.2003, p. 868-871.

Research output: Contribution to journalArticle

@article{362f88aff5584af282acd46810d1501f,
title = "Role of endoscopic retrograde cholangiopancreatography in the management of suspected choledocholithiasis",
abstract = "Background: Indications for endoscopic retrograde cholangiopancreatography (ERCP) are not precisely defined. With the increasing availability of magnetic resonance cholangiopancreatography (MRCP) and several prospective studies proving the accuracy of this modality, it is important to select appropriate criteria for invasive testing when common bile duct (CBD) pathology is suspected. Methods: We reviewed 200 consecutive ERCPs performed for jaundice, pancreatitis, noninvasive visualization of CBD stones, radiologic evidence of CBD dilatation, elevated liver function tests, or biliary colic. Diagnostic and therapeutic yields are determined for each indication and various combinations thereof. Results: Of the 180 ERCPs performed for suspected choledocholithiasis, 97 (53.8{\%}) were performed for multiple indications, whereas 83 (46.2{\%}) were performed for only one indication. One hundred two patients (56.6{\%}) had CBD pathology, whereas 78 explorations (43.4{\%}) were negative. If multiple indications for ERCP were present, the diagnostic yield was 85.6{\%}. When there was only one indication, the diagnostic yield decreased to 25.3{\%}. Conclusions: ERCP is an invasive procedure with significant morbidity that should be used selectively. MRCP may be a more appropriate initial evaluation of suspected CBD pathology in many patients.",
keywords = "Choledocholithiasis, Common bile duct, Endoscopic retro grade cholangiopancreatography, Magnetic resonance cholangiopancreatography",
author = "Sharma, {S. K.} and Larson, {K. A.} and Z. Adler and Goldfarb, {M. A.}",
year = "2003",
month = "6",
day = "1",
doi = "10.1007/s00464-002-8704-2",
language = "English",
volume = "17",
pages = "868--871",
journal = "Surgical Endoscopy and Other Interventional Techniques",
issn = "0930-2794",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Role of endoscopic retrograde cholangiopancreatography in the management of suspected choledocholithiasis

AU - Sharma, S. K.

AU - Larson, K. A.

AU - Adler, Z.

AU - Goldfarb, M. A.

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Background: Indications for endoscopic retrograde cholangiopancreatography (ERCP) are not precisely defined. With the increasing availability of magnetic resonance cholangiopancreatography (MRCP) and several prospective studies proving the accuracy of this modality, it is important to select appropriate criteria for invasive testing when common bile duct (CBD) pathology is suspected. Methods: We reviewed 200 consecutive ERCPs performed for jaundice, pancreatitis, noninvasive visualization of CBD stones, radiologic evidence of CBD dilatation, elevated liver function tests, or biliary colic. Diagnostic and therapeutic yields are determined for each indication and various combinations thereof. Results: Of the 180 ERCPs performed for suspected choledocholithiasis, 97 (53.8%) were performed for multiple indications, whereas 83 (46.2%) were performed for only one indication. One hundred two patients (56.6%) had CBD pathology, whereas 78 explorations (43.4%) were negative. If multiple indications for ERCP were present, the diagnostic yield was 85.6%. When there was only one indication, the diagnostic yield decreased to 25.3%. Conclusions: ERCP is an invasive procedure with significant morbidity that should be used selectively. MRCP may be a more appropriate initial evaluation of suspected CBD pathology in many patients.

AB - Background: Indications for endoscopic retrograde cholangiopancreatography (ERCP) are not precisely defined. With the increasing availability of magnetic resonance cholangiopancreatography (MRCP) and several prospective studies proving the accuracy of this modality, it is important to select appropriate criteria for invasive testing when common bile duct (CBD) pathology is suspected. Methods: We reviewed 200 consecutive ERCPs performed for jaundice, pancreatitis, noninvasive visualization of CBD stones, radiologic evidence of CBD dilatation, elevated liver function tests, or biliary colic. Diagnostic and therapeutic yields are determined for each indication and various combinations thereof. Results: Of the 180 ERCPs performed for suspected choledocholithiasis, 97 (53.8%) were performed for multiple indications, whereas 83 (46.2%) were performed for only one indication. One hundred two patients (56.6%) had CBD pathology, whereas 78 explorations (43.4%) were negative. If multiple indications for ERCP were present, the diagnostic yield was 85.6%. When there was only one indication, the diagnostic yield decreased to 25.3%. Conclusions: ERCP is an invasive procedure with significant morbidity that should be used selectively. MRCP may be a more appropriate initial evaluation of suspected CBD pathology in many patients.

KW - Choledocholithiasis

KW - Common bile duct

KW - Endoscopic retro grade cholangiopancreatography

KW - Magnetic resonance cholangiopancreatography

UR - http://www.scopus.com/inward/record.url?scp=0038318824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038318824&partnerID=8YFLogxK

U2 - 10.1007/s00464-002-8704-2

DO - 10.1007/s00464-002-8704-2

M3 - Article

C2 - 12618941

AN - SCOPUS:0038318824

VL - 17

SP - 868

EP - 871

JO - Surgical Endoscopy and Other Interventional Techniques

JF - Surgical Endoscopy and Other Interventional Techniques

SN - 0930-2794

IS - 6

ER -